These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1066 related items for PubMed ID: 15236877

  • 1. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
    Ozyar E, Gurkaynak M, Yildiz F, Atahan IL.
    Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
    [Abstract] [Full Text] [Related]

  • 2. Treatment results of 59 young patients with nasopharyngeal carcinoma.
    Selek U, Ozyar E, Ozyigit G, Varan A, Buyukpamukcu M, Atahan IL.
    Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):201-7. PubMed ID: 15656953
    [Abstract] [Full Text] [Related]

  • 3. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
    Song CH, Wu HG, Heo DS, Kim KH, Sung MW, Park CI.
    Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
    [Abstract] [Full Text] [Related]

  • 4. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):427-36. PubMed ID: 15380576
    [Abstract] [Full Text] [Related]

  • 5. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B, Li YX, Fang H, Jin J, Liu XF, Yu ZH.
    Ai Zheng; 2006 Apr 01; 25(4):465-70. PubMed ID: 16613682
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy.
    Chua DT, Nicholls JM, Sham JS, Au GK.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):11-20. PubMed ID: 15093894
    [Abstract] [Full Text] [Related]

  • 7. Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma.
    Al-Amro A, Al-Rajhi N, Khafaga Y, Memon M, Al-Hebshi A, El-Enbabi A, El-Husseiny G, Radawi A, Belal A, Allam A, El-Sebaie M.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):508-13. PubMed ID: 15890594
    [Abstract] [Full Text] [Related]

  • 8. Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
    Turen S, Ozyar E, Altundag K, Gullu I, Atahan IL.
    Cancer Invest; 2007 Aug 01; 25(5):315-21. PubMed ID: 17661206
    [Abstract] [Full Text] [Related]

  • 9. Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a Rare Cancer Network study.
    Ozyar E, Selek U, Laskar S, Uzel O, Anacak Y, Ben-Arush M, Polychronopoulou S, Akman F, Wolden SL, Sarihan S, Miller RC, Ozsahin M, Abacioğlu U, Martin M, Caloglu M, Scandolaro L, Szutowicz E, Atahan IL.
    Radiother Oncol; 2006 Oct 01; 81(1):39-46. PubMed ID: 16965827
    [Abstract] [Full Text] [Related]

  • 10. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
    Chua DT, Wei WI, Sham JS, Cheng AC, Au G.
    Head Neck; 2003 Jul 01; 25(7):585-94. PubMed ID: 12808662
    [Abstract] [Full Text] [Related]

  • 11. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, Leung SF, Zee B, Chan AT.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1440-50. PubMed ID: 15590175
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.
    Ai Zheng; 2006 Dec 01; 25(12):1543-9. PubMed ID: 17166383
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma. A significant factor in local control and distant metastasis.
    Chua DT, Sham JS, Kwong DL, Choy DT, Au GK, Wu PM.
    Cancer; 1996 Jul 15; 78(2):202-10. PubMed ID: 8673993
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM, Moore KN, Myers TK, Lanneau GS, McMeekin DS, Walker JL, Gold MA.
    Gynecol Oncol; 2009 Feb 15; 112(2):337-41. PubMed ID: 19041126
    [Abstract] [Full Text] [Related]

  • 20. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
    Chua DT, Sham JS, Choy D, Lorvidhaya V, Sumitsawan Y, Thongprasert S, Vootiprux V, Cheirsilpa A, Azhar T, Reksodiputro AH.
    Cancer; 1998 Dec 01; 83(11):2270-83. PubMed ID: 9840526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.